HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NK cell dynamics and association with molecular response in early chronic phase chronic myelogenous leukemia (CML-CP) patients treated with nilotinib.

AuthorsS Sopper, S Mustjoki, B T Gjertsen, F Giles, A Hochhaus, J J W M Janssen, K Porkka, D Wolf
JournalLeukemia (Leukemia) Vol. 31 Issue 10 Pg. 2264-2267 (10 2017) ISSN: 1476-5551 [Electronic] England
PMID28744011 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Pyrimidines
  • nilotinib
Topics
  • Antineoplastic Agents (therapeutic use)
  • Cell Line
  • Humans
  • K562 Cells
  • Killer Cells, Natural (drug effects)
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (diet therapy)
  • Leukemia, Myeloid, Chronic-Phase (drug therapy)
  • Leukocytes, Mononuclear (drug effects)
  • Lymphocytes (drug effects)
  • Pyrimidines (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: